ABCA5 p.Pro217Ser
c.649C>T · VCV4635933
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3759 | ambiguous |
|---|---|---|
| REVEL | 0.269 | benign-leaning |
| SaProt | LLR -2.00 | tolerated |
| ⇒ REVEL and SaProt both call this tolerated; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 8.4 | GERP 0.7, phastCons 1 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 67 kb · p 0.22 · regional, not allelic |
| Overall | ||
| CADD | 21.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0119% | 8,390 |
| Remaining individualsnot grpmax-eligible | 0.00323% | 30,961 |
| African / African-American | 0.00269% | 37,188 |
| East Asian | 0.00226% | 44,182 |
| Finnishnot grpmax-eligible | 0.00157% | 63,680 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ABCA5
- Protein
- p.Pro217Ser
- Coding
- c.649C>T
- MANE Select
- NM_172232
- Type
- single nucleotide variant
- Location
- chr17:69306864 (GRCh38)
- Gene constraint
- LOEUF 0.97 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 77.12
Similar variants
- ABCA5 p.Ser288Phe Uncertain significance ★★ ⚠ same type
- ABCA5 c.4765+3A>G Likely benign ★★ same type
- ABCA5 p.Asn190Ser Likely benign ★★ ⚠ same type
- ABCA5 p.Asn768Asp Benign ★★ same type
- ABCA5 p.Asp817Tyr Likely benign ★★ ⚠ same type
- ABCA5 p.Gly1159Arg Likely benign ★★ ⚠ same type
- ABCA5 p.Gly128= Benign/Likely benign ★★ same type
- ABCA5 p.Ile1173Val Likely benign ★★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abca5-p-pro217ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown